AlphaStocks
5.5
Consider Buy

WEST PHARMACEUTICAL SERVICES INC (WST)

Health Care / Health Care Supplies

S&P 500

$252.83

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

#429out of 1127 in Health Care

Is WEST PHARMACEUTICAL SERVICES INC a Good Investment in 2026?

WEST PHARMACEUTICAL SERVICES INC (WST) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates WEST PHARMACEUTICAL SERVICES INC as Strong (7/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. WEST PHARMACEUTICAL SERVICES INC currently trades above its estimated fair value of $200, suggesting limited upside at current prices. WEST PHARMACEUTICAL SERVICES INC ranks #429 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E37.2ROE11.4Market Cap18B

Estimated Fair Value

$199.8627% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

High PEG — growth premium · Stalwart

Greenblatt

Neutral

Top half (rank 46%)

Frequently Asked Questions

Is WEST PHARMACEUTICAL SERVICES INC (WST) a good investment?
Based on AlphaStocks' composite analysis, WEST PHARMACEUTICAL SERVICES INC (WST) scores 5.5 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading slightly above estimated fair value.
What is WEST PHARMACEUTICAL SERVICES INC's Piotroski F-Score?
WEST PHARMACEUTICAL SERVICES INC's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is WST overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $200, WST appears overvalued. The stock currently trades 27% above its estimated fair value. Trading slightly above estimated fair value.
How does WST compare to other Health Care stocks?
WEST PHARMACEUTICAL SERVICES INC ranks #429 out of 1127 stocks in the Health Care sector, placing it in the top 38% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about WST?
AlphaStocks evaluates WST using five proven investment models. Piotroski: Strong; Buffett: Strong; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.5/10.

Similar Stocks

PARRFTIAZN

Compare WST with

WST vs PARRWST vs FTIWST vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer